Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes.

Brandt B, Sioulas V, Basaran D, Kuhn T, LaVigne K, Gardner GJ, Sonoda Y, Chi DS, Long Roche KC, Mueller JJ, Jewell EL, Broach VA, Zivanovic O, Abu-Rustum NR, Leitao MM Jr.

Gynecol Oncol. 2020 Jan 7. pii: S0090-8258(19)31868-2. doi: 10.1016/j.ygyno.2019.12.038. [Epub ahead of print]

PMID:
31918996
2.

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery.

Liu YL, Filippova OT, Zhou Q, Iasonos A, Chi DS, Zivanovic O, Sonoda Y, Gardner GJ, Broach VA, O'Cearbhaill RE, Konner JA, Aghajanian C, Long Roche K, Tew WP.

J Gynecol Oncol. 2020 Jan;31(1):e17. doi: 10.3802/jgo.2020.31.e17.

3.

Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.

Leitao MM Jr, Zhou QC, Gomez-Hidalgo NR, Iasonos A, Baser R, Mezzancello M, Chang K, Ward J, Chi DS, Long Roche K, Sonoda Y, Brown CL, Mueller JJ, Gardner GJ, Jewell EL, Broach V, Zivanovic O, Dowdy SC, Mariani A, Abu-Rustum NR.

Gynecol Oncol. 2020 Jan;156(1):147-153. doi: 10.1016/j.ygyno.2019.11.003. Epub 2019 Nov 25.

PMID:
31780238
4.

State of the science: Evolving role of surgery for the treatment of ovarian cancer.

Long Roche K, Gardner GJ.

Gynecol Oncol. 2019 Oct;155(1):3-7. doi: 10.1016/j.ygyno.2019.08.016. Epub 2019 Aug 29. Review. No abstract available.

PMID:
31472939
5.

Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status.

Stasenko M, Cybulska P, Feit N, Makker V, Konner J, O'Cearbhaill RE, Alektiar KM, Beal K, Gardner GJ, Long Roche KC, Sonoda Y, Chi DS, Zivanovic O, Leitao MM Jr, Cadoo KA, Tew WP.

Gynecol Oncol. 2019 Jul;154(1):144-149. doi: 10.1016/j.ygyno.2019.05.004. Epub 2019 May 18.

PMID:
31113680
6.

Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.

Filippova OT, Chi DS, Long Roche K, Sonoda Y, Zivanovic O, Gardner GJ, Tew WP, O'Cearbhaill R, Sarraf S, Sun SW, Alexander K, Korc-Grodzicki B, Shahrokni A.

Gynecol Oncol. 2019 Jul;154(1):77-82. doi: 10.1016/j.ygyno.2019.04.683. Epub 2019 May 8.

PMID:
31078241
7.

Is Robotic-Assisted Surgery Safe in the Elderly Population? An Analysis of Gynecologic Procedures in Patients ≥ 65 Years Old.

Aloisi A, Tseng JH, Sandadi S, Callery R, Feinberg J, Kuhn T, Gardner GJ, Sonoda Y, Brown CL, Jewell EL, Barakat RR, Leitao MM Jr.

Ann Surg Oncol. 2019 Jan;26(1):244-251. doi: 10.1245/s10434-018-6997-1. Epub 2018 Nov 12.

8.

A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer.

Tanner EJ, Filippova OT, Gardner GJ, Long Roche KC, Sonoda Y, Zivanovic O, Fischer M, Chi DS.

Gynecol Oncol. 2018 Dec;151(3):433-437. doi: 10.1016/j.ygyno.2018.10.006. Epub 2018 Oct 16.

9.

Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?

Tseng JH, Cowan RA, Zhou Q, Iasonos A, Byrne M, Polcino T, Polen-De C, Gardner GJ, Sonoda Y, Zivanovic O, Abu-Rustum NR, Long Roche K, Chi DS.

Gynecol Oncol. 2018 Oct;151(1):24-31. doi: 10.1016/j.ygyno.2018.08.014. Epub 2018 Aug 17.

10.

Long-Term Oncologic Outcomes of Uterine-Preserving Surgery in Young Women With Stage Ib1 Cervical Cancer.

Tseng JH, Aloisi A, Sonoda Y, Gardner GJ, Zivanovic O, Abu-Rustum NR, Leitao MM Jr.

Int J Gynecol Cancer. 2018 Sep;28(7):1350-1359. doi: 10.1097/IGC.0000000000001319.

11.

Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.

Tseng JH, Aloisi A, Sonoda Y, Gardner GJ, Zivanovic O, Abu-Rustum NR, Leitao MM Jr.

Gynecol Oncol. 2018 Jul;150(1):44-49. doi: 10.1016/j.ygyno.2018.04.571.

12.

Prospective Comparative Study of Laparoscopic Narrow Band Imaging (NBI) Versus Standard Imaging in Gynecologic Oncology.

Aloisi A, Sonoda Y, Gardner GJ, Park KJ, Elliott SL, Zhou QC, Iasonos A, Abu-Rustum NR.

Ann Surg Oncol. 2018 Apr;25(4):984-990. doi: 10.1245/s10434-017-6314-4. Epub 2018 Jan 16.

13.

Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.

Oseledchyk A, Leitao MM Jr, Konner J, O'Cearbhaill RE, Zamarin D, Sonoda Y, Gardner GJ, Long Roche K, Aghajanian CA, Grisham RN, Brown CL, Snyder A, Chi DS, Soslow RA, Abu-Rustum NR, Zivanovic O.

Ann Oncol. 2017 Dec 1;28(12):2985-2993. doi: 10.1093/annonc/mdx525.

14.

Trocar site hernia development in patients undergoing robotically assisted or standard laparoscopic staging surgery for endometrial cancer.

Cybulska P, Schiavone MB, Sawyer B, Gardner GJ, Zivanovic O, Brown CL, Jewell EL, Sonoda Y, Barakat RR, Abu-Rustum NR, Leitao MM Jr.

Gynecol Oncol. 2017 Nov;147(2):371-374. doi: 10.1016/j.ygyno.2017.09.005. Epub 2017 Sep 22.

15.

Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.

Cowan RA, Tseng J, Murthy V, Srivastava R, Long Roche KC, Zivanovic O, Gardner GJ, Chi DS, Park BJ, Sonoda Y.

Gynecol Oncol. 2017 Nov;147(2):262-266. doi: 10.1016/j.ygyno.2017.09.001. Epub 2017 Sep 6.

16.

Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.

Eriksson AGZ, Graul A, Yu MC, Halko A, Chi DS, Zivanovic O, Gardner GJ, Sonoda Y, Barakat RR, Abu-Rustum NR, Leitao MM Jr.

Gynecol Oncol. 2017 Aug;146(2):263-267. doi: 10.1016/j.ygyno.2017.05.022. Epub 2017 May 17.

PMID:
28527673
17.

A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer.

Eriksson AG, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Long Roche K, Sonoda Y, Leitao MM Jr, Jewell EL.

Int J Gynecol Cancer. 2017 May;27(4):743-747. doi: 10.1097/IGC.0000000000000959.

18.

A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer.

Cowan RA, Eriksson AGZ, Jaber SM, Zhou Q, Iasonos A, Zivanovic O, Leitao MM Jr, Abu-Rustum NR, Chi DS, Gardner GJ.

Gynecol Oncol. 2017 May;145(2):230-235. doi: 10.1016/j.ygyno.2017.02.010. Epub 2017 Mar 9.

PMID:
28285846
19.

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

Sioulas VD, Schiavone MB, Kadouri D, Zivanovic O, Roche KL, O'Cearbhaill R, Abu-Rustum NR, Levine DA, Sonoda Y, Gardner GJ, Leitao MM Jr, Chi DS.

Gynecol Oncol. 2017 Apr;145(1):15-20. doi: 10.1016/j.ygyno.2017.02.023. Epub 2017 Feb 21.

20.

Abdominal wall endometriosis: differentiation from other masses using CT features.

Yarmish G, Sala E, Goldman DA, Lakhman Y, Soslow RA, Hricak H, Gardner GJ, Vargas HA.

Abdom Radiol (NY). 2017 May;42(5):1517-1523. doi: 10.1007/s00261-016-0998-y.

21.

Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.

Sioulas VD, Jorge S, Chern JY, Schiavone MB, Weiser MR, Kelvin JF, Gardner GJ, Sonoda Y, Abu-Rustum NR, Goodman KA, Leitao MM Jr.

Ann Surg Oncol. 2017 Jan;24(1):251-256. doi: 10.1245/s10434-016-5650-0. Epub 2016 Nov 9.

22.

Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center.

Mueller JJ, Kelly A, Zhou Q, Iasonos A, Long Roche K, Sonoda Y, O'Cearbhaill RE, Zivanovic O, Chi DS, Gardner GJ.

Gynecol Oncol. 2016 Dec;143(3):496-503. doi: 10.1016/j.ygyno.2016.09.014. Epub 2016 Sep 28.

23.

Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18].

Schlappe BA, Mueller JJ, Zivanovic O, Gardner GJ, Long Roche K, Sonoda Y, Chi DS, O'Cearbhaill RE.

Gynecol Oncol. 2016 Oct;143(1):225. doi: 10.1016/j.ygyno.2016.07.097. Epub 2016 Aug 3. No abstract available.

PMID:
27496397
24.

Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes.

Tseng JH, Suidan RS, Zivanovic O, Gardner GJ, Sonoda Y, Levine DA, Abu-Rustum NR, Tew WP, Chi DS, Long Roche K.

Gynecol Oncol. 2016 Aug;142(2):217-24. doi: 10.1016/j.ygyno.2016.05.035. Epub 2016 Jun 4.

25.

Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.

Schlappe BA, Mueller JJ, Zivanovic O, Gardner GJ, Long Roche K, Sonoda Y, Chi DS, O'Cearbhaill RE.

Gynecol Oncol. 2016 Jul;142(1):13-18. doi: 10.1016/j.ygyno.2016.05.015. Epub 2016 May 21. Erratum in: Gynecol Oncol. 2016 Oct;143(1):225.

26.

A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease.

Cowan RA, Black DR, Hoang LN, Park KJ, Soslow RA, Backes FJ, Gardner GJ, Abu-Rustum NR, Leitao MM Jr, Eisenhauer EL, Chi DS.

Gynecol Oncol. 2016 Jul;142(1):139-143. doi: 10.1016/j.ygyno.2016.04.028. Epub 2016 May 5.

27.

Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery.

Eriksson AG, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Barakat RR, Brown CL, Levine DA, Sonoda Y, Leitao MM Jr, Jewell EL.

Ann Surg Oncol. 2016 Aug;23(8):2522-8. doi: 10.1245/s10434-016-5134-2. Epub 2016 Feb 23.

28.

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.

Mueller JJ, Zhou QC, Iasonos A, O'Cearbhaill RE, Alvi FA, El Haraki A, Eriksson AG, Gardner GJ, Sonoda Y, Levine DA, Aghajanian C, Chi DS, Abu-Rustum NR, Zivanovic O.

Gynecol Oncol. 2016 Mar;140(3):436-42. doi: 10.1016/j.ygyno.2016.01.008. Epub 2016 Jan 9.

29.

Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer.

Schiavone MB, Bielen MS, Gardner GJ, Zivanovic O, Jewell EL, Sonoda Y, Barakat RR, Chi DS, Abu-Rustum NR, Leitao MM Jr.

Gynecol Oncol. 2016 Mar;140(3):383-6. doi: 10.1016/j.ygyno.2016.01.010. Epub 2016 Jan 8.

30.

Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer.

Leitao MM, Narain WR, Boccamazzo D, Sioulas V, Cassella D, Ducie JA, Eriksson AG, Sonoda Y, Chi DS, Brown CL, Levine DA, Jewell EL, Zivanovic O, Barakat RR, Abu-Rustum NR, Gardner GJ.

Ann Surg Oncol. 2016 Jul;23(7):2192-8. doi: 10.1245/s10434-015-5062-6. Epub 2016 Jan 7.

31.

Is It Time to Centralize Ovarian Cancer Care in the United States?

Cowan RA, O'Cearbhaill RE, Gardner GJ, Levine DA, Roche KL, Sonoda Y, Zivanovic O, Tew WP, Sala E, Lakhman Y, Vargas Alvarez HA, Sarasohn DM, Mironov S, Abu-Rustum NR, Chi DS.

Ann Surg Oncol. 2016 Mar;23(3):989-93. doi: 10.1245/s10434-015-4938-9. Epub 2015 Oct 28. Review.

32.

Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.

Mueller JJ, Holzapfel M, Han CH, Santos K, Gunderson C, Moore K, Erickson B, Leath CA 3rd, Diaz E, Walsh C, Wethington SL, Dejbakhsh SZ, Barakat RR, Gardner GJ, Hyman DM, Soslow RA, Leitao MM Jr.

Int J Gynecol Cancer. 2016 Jan;26(1):120-4. doi: 10.1097/IGC.0000000000000559.

33.

Development of a risk stratification system to guide treatment for female germ cell tumors.

Meisel JL, Woo KM, Sudarsan N, Eng J, Patil S, Jacobsen EP, Murali R, Gardner GJ, Bosl GJ, Aghajanian C, Feldman DR.

Gynecol Oncol. 2015 Sep;138(3):566-72. doi: 10.1016/j.ygyno.2015.06.029. Epub 2015 Jun 24.

34.

Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.

Suidan RS, Leitao MM Jr, Zivanovic O, Gardner GJ, Long Roche KC, Sonoda Y, Levine DA, Jewell EL, Brown CL, Abu-Rustum NR, Charlson ME, Chi DS.

Gynecol Oncol. 2015 Aug;138(2):246-51. doi: 10.1016/j.ygyno.2015.05.034. Epub 2015 May 31.

35.

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Mironov S, Iyer RB, Zhou Q, Iasonos A, Paul H, Hosaka M, Aghajanian CA, Leitao MM Jr, Gardner GJ, Abu-Rustum NR, Sonoda Y, Levine DA, Hricak H, Chi DS.

Gynecol Oncol. 2014 Sep;134(3):455-61. doi: 10.1016/j.ygyno.2014.07.002. Epub 2014 Jul 11.

36.

Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers.

Leitao MM Jr, Bartashnik A, Wagner I, Lee SJ, Caroline A, Hoskins WJ, Thaler HT, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell EL, Barakat RR, Gardner GJ.

Obstet Gynecol. 2014 May;123(5):1031-7. doi: 10.1097/AOG.0000000000000223.

37.

The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications.

Lee SJ, Calderon B, Gardner GJ, Mays A, Nolan S, Sonoda Y, Barakat RR, Leitao MM Jr.

Gynecol Oncol. 2014 Jun;133(3):552-5. doi: 10.1016/j.ygyno.2014.04.006. Epub 2014 Apr 13.

PMID:
24736022
38.

Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies.

Jewell EL, Huang JJ, Abu-Rustum NR, Gardner GJ, Brown CL, Sonoda Y, Barakat RR, Levine DA, Leitao MM Jr.

Gynecol Oncol. 2014 May;133(2):274-7. doi: 10.1016/j.ygyno.2014.02.028. Epub 2014 Feb 28.

39.

Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy.

Sandadi S, Gadzinski JA, Lee S, Chi DS, Sonoda Y, Jewell EL, Brown CL, Gardner GJ, Barakat RR, Leitao MM Jr.

Gynecol Oncol. 2014 Jan;132(1):102-6. doi: 10.1016/j.ygyno.2013.11.017. Epub 2013 Nov 18.

PMID:
24262878
40.

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).

Wethington SL, Park KJ, Soslow RA, Kauff ND, Brown CL, Dao F, Otegbeye E, Sonoda Y, Abu-Rustum NR, Barakat RR, Levine DA, Gardner GJ.

Int J Gynecol Cancer. 2013 Nov;23(9):1603-11. doi: 10.1097/IGC.0b013e3182a80ac8.

41.

Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity.

Long KC, Tanner EJ, Frey M, Leitao MM Jr, Levine DA, Gardner GJ, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS.

Gynecol Oncol. 2013 Dec;131(3):525-30. doi: 10.1016/j.ygyno.2013.08.034. Epub 2013 Sep 7.

PMID:
24016410
42.

Postoperative pain medication requirements in patients undergoing computer-assisted (“Robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer.

Leitao MM Jr, Malhotra V, Briscoe G, Suidan R, Dholakiya P, Santos K, Jewell EL, Brown CL, Sonoda Y, Abu-Rustum NR, Barakat RR, Gardner GJ.

Ann Surg Oncol. 2013 Oct;20(11):3561-7.

PMID:
23797751
43.

Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?

Barlin JN, Long KC, Tanner EJ, Gardner GJ, Leitao MM Jr, Levine DA, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS.

Gynecol Oncol. 2013 Aug;130(2):284-8. doi: 10.1016/j.ygyno.2013.05.006. Epub 2013 May 11.

PMID:
23672929
44.

Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer.

Milgrom SA, Kollmeier MA, Abu-Rustum NR, Makker V, Gardner GJ, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Jul;130(1):49-53. doi: 10.1016/j.ygyno.2013.04.013. Epub 2013 Apr 16.

45.

Tumoral displacement into fallopian tubes in patients undergoing robotically assisted hysterectomy for newly diagnosed endometrial cancer.

Delair D, Soslow RA, Gardner GJ, Barakat RR, Leitao MM Jr.

Int J Gynecol Pathol. 2013 Mar;32(2):188-92. doi: 10.1097/PGP.0b013e31825f7c08.

PMID:
23370655
46.

Management of uterine adenosarcomas with and without sarcomatous overgrowth.

Tanner EJ, Toussaint T, Leitao MM Jr, Hensley ML, Soslow RA, Gardner GJ, Jewell EL.

Gynecol Oncol. 2013 Apr;129(1):140-4. doi: 10.1016/j.ygyno.2012.12.036. Epub 2012 Dec 30.

PMID:
23283300
47.

Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer.

Shih KK, Milgrom SA, Abu-Rustum NR, Kollmeier MA, Gardner GJ, Tew WP, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Mar;128(3):535-9. doi: 10.1016/j.ygyno.2012.11.020. Epub 2012 Nov 20.

PMID:
23174538
48.

Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer.

Sandadi S, Lee S, Walter A, Gardner GJ, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell E, Parameswaran R, Barakat RR, Leitao MM Jr.

Obstet Gynecol. 2012 Nov;120(5):1077-83. doi: http://10.1097/AOG.0b013e31826c31fb.

PMID:
23090525
49.

Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.

Tanner EJ, Long KC, Feffer JB, Leitao MM Jr, Abu-Rustum NR, Barakat RR, Chi DS, Gardner GJ.

Gynecol Oncol. 2013 Jan;128(1):28-33. doi: 10.1016/j.ygyno.2012.09.019. Epub 2012 Sep 25.

PMID:
23017819
50.

Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.

Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C, Abu-Rustum NR, Barakat RR, Alektiar KM.

Gynecol Oncol. 2012 Nov;127(2):321-5. doi: 10.1016/j.ygyno.2012.07.112. Epub 2012 Jul 28.

PMID:
22850412

Supplemental Content

Loading ...
Support Center